When should thyroid peroxidase (TPO) antibodies be checked?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Check TPO Antibodies

TPO antibodies should be checked at the time of type 1 diabetes diagnosis, and can be considered in any patient with suspected autoimmune thyroid disease or high-normal TSH levels (2.5-5.49 IU/ml) to identify those at risk for developing hypothyroidism. 1

Primary Indication: Type 1 Diabetes

In patients with type 1 diabetes, check TPO antibodies (along with thyroglobulin antibodies) soon after diagnosis. 1

  • Autoimmune thyroid disease occurs in 17-30% of patients with type 1 diabetes, making it the most common associated autoimmune disorder. 1
  • Approximately 25% of children with type 1 diabetes have thyroid autoantibodies at diagnosis. 1
  • TPO antibodies are more predictive of thyroid dysfunction than thyroglobulin antibodies in multivariate analysis. 1
  • The presence of thyroid autoantibodies predicts future thyroid dysfunction—most commonly hypothyroidism (though hyperthyroidism occurs in ~0.5% of cases). 1

Important Timing Consideration

  • Thyroid function tests may be misleading if performed at initial diabetes diagnosis due to euthyroid sick syndrome from previous hyperglycemia, ketosis, or weight loss. 1
  • Measure TSH after metabolic control has been established or when clinically stable, then recheck every 1-2 years if normal. 1

Secondary Indications: General Population

High-Normal TSH Levels

Consider checking TPO antibodies in patients with TSH between 2.5-5.49 IU/ml to identify those at increased risk of progression to overt hypothyroidism. 2

  • The prevalence of positive TPO antibodies is 18.6% in patients with high-normal TSH (2.5-5.49 IU/ml) versus only 3% in those with low-normal TSH (0.36-2.49 IU/ml). 2
  • Patients with positive thyroid antibodies have a 4.3% per year risk of developing overt hypothyroidism versus 2.6% per year in antibody-negative individuals. 3

Suspected Autoimmune Thyroid Disease

Check TPO antibodies when evaluating for Hashimoto's thyroiditis or Graves' disease. 4, 5

  • TPO antibodies have 96% sensitivity for Hashimoto's thyroiditis and 59% sensitivity for Graves' disease (using a cutoff of 200 units/ml). 5
  • Clearly elevated anti-TPO values (>500 units/ml) are found in 59% of patients with thyroiditis but in none of the healthy controls. 5
  • The highest frequency of positive results (88%) occurs in patients with autoimmune hypothyroidism. 5

Clinical Scenarios Warranting Testing

Check TPO antibodies in patients presenting with: 4

  • Goiter evaluation 4
  • Subclinical thyroid disease to predict risk of progression to overt hypothyroidism 4
  • Symptoms suggestive of thyroid dysfunction with borderline TSH 1
  • Unexplained glycemic variability in diabetic patients 1

Key Clinical Pitfalls

  • Do not check TPO antibodies at the time of acute illness or metabolic derangement, as thyroid function tests may be unreliable due to euthyroid sick syndrome. 1
  • TPO antibodies identify autoimmune etiology but do not require treatment if thyroid function is normal—the primary value is risk stratification for future dysfunction. 3
  • Once positive TPO antibodies are identified, regular monitoring of thyroid function (TSH, free T4) every 6-12 months is essential. 3
  • Treatment with levothyroxine is indicated if TSH rises above 10 mIU/L or if symptoms of hypothyroidism develop, not based on antibody levels alone. 3, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.